Nuvalent

(NASDAQ) NUVL

Current Price$107.13

Market Cap$8.09B

Since IPO (2021)+456%

5 YearN/A

1 Year+53%

1 Month+0%

Nuvalent Financials at a Glance

Market Cap

$8.09B

Revenue (TTM)

$0.00

Net Income (TTM)

$450.07M

EPS (TTM)

$-5.85

P/E Ratio

-17.50

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$107.13

Volume

2,124

Open

$103.61

Price

$107.13

Volume

2,124

Open

$103.61

Previous Close

$102.40

Daily Range

$102.85 - $107.53

52-Week Range

$68.64 - $113.02

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$107.13

Volume

2,124

Open

$103.61

Previous Close

$102.40

Daily Range

$102.85 - $107.53

52-Week Range

$68.64 - $113.02

NUVL News

This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally

Jonathan PoncianoMar 16, 2026

Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29%

Jonathan PoncianoFeb 23, 2026

Biotech Stock Gets Booted in Latest Fund Update

Jake LerchNov 19, 2025

NUVL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nuvalent

Industry

Biotechnology

Sector

Health Care

Employees

228

CEO

James R. Porter, PhD

Website

www.nuvalent.com

Headquarters

Cambridge, MA 02142, US

NUVL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-37%

Return on Capital

-35%

Return on Assets

-34%

Earnings Yield

-5.71%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.09B

Shares Outstanding

78.98M

Volume

2.12K

Avg. Volume

559.97K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$414.31M

EBITDA

$10.48M

Operating Cash Flow

$275.21M

Capital Expenditure

$0.00

Free Cash Flow

$275.21M

Cash & ST Invst.

$1.37B

Total Debt

$0.00

Nuvalent Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$8.09B

N/A

Market Cap/Employee

$49.92M

N/A

Employees

162

N/A

Net Income

$109.28M

-29.2%

EBITDA

$119.41M

-25.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$1.29B

+20.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-33.81%

N/A

Return on Invested Capital

-35.11%

N/A

Free Cash Flow

$92.40M

-68.5%

Operating Cash Flow

$92.40M

-68.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABVXAbivax S.A.

ABVXAbivax S.A.$124.30-0.28%

PCVXVaxcyte, Inc.

PCVXVaxcyte, Inc.$52.73+2.43%

MTSRMetsera, Inc.

MTSRMetsera, Inc.$70.50-0.35%

MRUSMerus N.V.

MRUSMerus N.V.$90.00+0.00%

CYTKCytokinetics, Incorporated

CYTKCytokinetics, Incorporated$76.47+2.93%

RYTMRhythm Pharmaceuticals, Inc.

RYTMRhythm Pharmaceuticals, Inc.$95.90-0.34%

ARWRArrowhead Pharmaceuticals, Inc.

ARWRArrowhead Pharmaceuticals, Inc.$74.56-4.34%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.57+0.08%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.53+0.04%

FLNCFluence Energy

FLNCFluence Energy$25.95+0.37%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.76-0.04%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$7.45-0.08%

IRENIren

IRENIren$62.05+0.09%

NVDANvidia

NVDANvidia$215.89+0.02%

Questions About NUVL

What is the current price of Nuvalent?

Nuvalent is trading at $107.13 per share.

What is the 52-week range for Nuvalent?

Over the past 52 weeks, Nuvalent has traded between $68.64 and $113.02.

How much debt does Nuvalent have?

As of the most recent reporting period, Nuvalent reported total debt of N/A.

How much cash does Nuvalent have on hand?

Nuvalent reported $159.73M in cash and cash equivalents in its most recent financial results.

What is Nuvalent’s dividend yield?

Nuvalent does not currently have a dividend yield.

Nuvalent

Nuvalent Financials at a Glance

NUVL News

This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally

Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29%

Biotech Stock Gets Booted in Latest Fund Update

Nuvalent (NUVL) Q2 R&D Up 65%

Why Nuvalent Stock Tanked on Tuesday

Why Nuvalent Stock Skyrocketed 35% This Week

Why Nuvalent Stock Was Soaring Wednesday

NUVL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nuvalent

NUVL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nuvalent Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NUVL

What is the current price of Nuvalent?

What is the 52-week range for Nuvalent?

How much debt does Nuvalent have?

How much cash does Nuvalent have on hand?

What is Nuvalent’s dividend yield?

Premium Investing Services